Sysmex Co. (OTCMKTS:SSMXY) Short Interest Down 66.7% in March

Sysmex Co. (OTCMKTS:SSMXY) saw a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 1,000 shares, a decrease of 66.7% from the February 28th total of 3,000 shares. Based on an average daily trading volume, of 109,300 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the shares of the stock are short sold.

Sysmex Price Performance

Shares of OTCMKTS SSMXY traded down $0.30 during mid-day trading on Friday, hitting $18.85. 58,485 shares of the company’s stock traded hands, compared to its average volume of 67,435. The company has a market capitalization of $11.87 billion, a P/E ratio of 36.87 and a beta of 0.88. Sysmex has a 1 year low of $14.38 and a 1 year high of $28.32. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.19 and a quick ratio of 2.42. The company’s 50-day moving average is $18.61 and its two-hundred day moving average is $19.10.

Sysmex (OTCMKTS:SSMXY) last issued its quarterly earnings results on Wednesday, February 12th. The company reported $0.17 earnings per share for the quarter. On average, equities analysts anticipate that Sysmex will post 0.57 EPS for the current fiscal year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.